Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that Douglas M. Fambrough, PhD, the Company’s President and CEO, will present at the 9th Annual JMP Securities Healthcare Conference on June 24 2014, at 1:00 PM ET in New York, NY.
Help employers find you! Check out all the jobs and post your resume.
